The present invention is directed to a compound represented by Structural Formula (I):
or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I) and its therapeutic use.
US9371283B2
申请人:——
公开号:US9371283B2
公开(公告)日:2016-06-21
[EN] POLYCYCLIC TETRACYCLINE COMPOUNDS<br/>[FR] COMPOSÉS POLYCYCLIQUES DE TÉTRACYCLINE